JP2022510947A5 - - Google Patents
Info
- Publication number
- JP2022510947A5 JP2022510947A5 JP2021530970A JP2021530970A JP2022510947A5 JP 2022510947 A5 JP2022510947 A5 JP 2022510947A5 JP 2021530970 A JP2021530970 A JP 2021530970A JP 2021530970 A JP2021530970 A JP 2021530970A JP 2022510947 A5 JP2022510947 A5 JP 2022510947A5
- Authority
- JP
- Japan
- Prior art keywords
- perampanel
- cyclodextrin
- pharmaceutical preparation
- pharmaceutical
- solubilizer
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779620P | 2018-12-14 | 2018-12-14 | |
| US62/779,620 | 2018-12-14 | ||
| PCT/US2019/066622 WO2020124090A1 (en) | 2018-12-14 | 2019-12-16 | Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022510947A JP2022510947A (ja) | 2022-01-28 |
| JP2022510947A5 true JP2022510947A5 (https=) | 2022-06-21 |
| JPWO2020124090A5 JPWO2020124090A5 (https=) | 2022-06-21 |
| JP7177937B2 JP7177937B2 (ja) | 2022-11-24 |
Family
ID=69174604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530970A Active JP7177937B2 (ja) | 2018-12-14 | 2019-12-16 | １，２－ジヒドロピリジン化合物の水性医薬製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12303499B2 (https=) |
| EP (1) | EP3893844A1 (https=) |
| JP (1) | JP7177937B2 (https=) |
| KR (1) | KR102912861B1 (https=) |
| CN (1) | CN113226286B (https=) |
| AU (1) | AU2019395288B2 (https=) |
| BR (1) | BR112021010953A2 (https=) |
| CA (1) | CA3122705A1 (https=) |
| MA (1) | MA54460A (https=) |
| MX (1) | MX2021006317A (https=) |
| WO (1) | WO2020124090A1 (https=) |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356902A (en) | 1992-11-06 | 1994-10-18 | Eli Lilly And Company | Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists |
| IL109397A0 (en) | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| HU219777B (hu) | 1993-07-02 | 2001-07-30 | Gyógyszerkutató Intézet Kft. | Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására |
| HU223945B1 (hu) | 1994-09-27 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | 1,2,3,4-Tetrahidro-kinoxalin-dion-származékok és ezeket tartalmazó gyógyszerkészítmények |
| US5935551A (en) | 1995-11-15 | 1999-08-10 | California Institute Of Technology | Synthesis of zeolites by hydrothermal reaction of zeolite P1 |
| DE19604920A1 (de) | 1996-02-01 | 1997-08-07 | Schering Ag | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
| US5891871A (en) | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| HU9600871D0 (en) | 1996-04-04 | 1996-05-28 | Gyogyszerkutato Intezet | New 2,3-benzodiazepine derivatives |
| KR100375155B1 (ko) | 1996-05-15 | 2003-08-19 | 화이자 인코포레이티드 | 신규한2,3-이치환된-4(3에이치)-퀴나졸리논 |
| DE19643037A1 (de) | 1996-10-18 | 1998-04-23 | Boehringer Ingelheim Kg | Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| SK113299A3 (en) | 1997-02-28 | 2001-05-10 | Pfizer Prod Inc | Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| GB9711753D0 (en) | 1997-06-06 | 1997-08-06 | Merck Sharp & Dohme | Therapeutic agents |
| JP2002519373A (ja) | 1998-07-02 | 2002-07-02 | エーザイ株式会社 | 製薬組成物及びそれらの使用 |
| DE19835918A1 (de) | 1998-08-07 | 2000-02-10 | Dresden Arzneimittel | Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung |
| IL152848A0 (en) | 2000-06-12 | 2003-06-24 | Eisai Co Ltd | 1,2-dihydropyridine derivatives, pharmaceutical compositions containing the same and methods for the production thereof |
| GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
| MY148809A (en) | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
| WO2007072869A1 (ja) * | 2005-12-21 | 2007-06-28 | Eisai R & D Management Co., Ltd. | １，２－ジヒドロピリジン化合物の非晶質体 |
| US20100099714A1 (en) * | 2007-03-05 | 2010-04-22 | Eisai R&D Management Co., Ltd. | AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases |
| JP2015227288A (ja) | 2012-08-31 | 2015-12-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | けいれん重積発作の治療用医薬組成物 |
| CN104644592A (zh) * | 2013-11-25 | 2015-05-27 | 天津市汉康医药生物技术有限公司 | 一种吡仑帕奈药物组合物及其制备方法 |
| CN104706604A (zh) * | 2013-12-12 | 2015-06-17 | 北京星昊医药股份有限公司 | 一种吡仑帕奈冻干口崩片及其制备方法 |
| EP4059522A1 (en) * | 2015-02-06 | 2022-09-21 | Marinus Pharmaceuticals, Inc. | Intravenous ganaxolone formulations and their use in treating status epilepticus and other seizure disorders |
| CN106389367B (zh) | 2016-11-16 | 2020-12-18 | 杭州朱养心药业有限公司 | 吡仑帕奈包衣片剂药物组合物 |
| WO2018169798A1 (en) * | 2017-03-11 | 2018-09-20 | The Regents Of The University Of California | Mitigation of cns disorders by combination therapy using neurosteroids, and ampa blockers |
-
2019
- 2019-12-16 WO PCT/US2019/066622 patent/WO2020124090A1/en not_active Ceased
- 2019-12-16 JP JP2021530970A patent/JP7177937B2/ja active Active
- 2019-12-16 EP EP19839214.4A patent/EP3893844A1/en active Pending
- 2019-12-16 CA CA3122705A patent/CA3122705A1/en active Pending
- 2019-12-16 CN CN201980081856.7A patent/CN113226286B/zh active Active
- 2019-12-16 BR BR112021010953-6A patent/BR112021010953A2/pt unknown
- 2019-12-16 MX MX2021006317A patent/MX2021006317A/es unknown
- 2019-12-16 AU AU2019395288A patent/AU2019395288B2/en active Active
- 2019-12-16 US US17/312,077 patent/US12303499B2/en active Active
- 2019-12-16 KR KR1020217017514A patent/KR102912861B1/ko active Active
- 2019-12-16 MA MA054460A patent/MA54460A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102215690B (zh) | 抗微生物组合物 | |
| JP2662518B2 (ja) | 酸不安定化合物を含有する腸溶性被覆経口薬の調製方法 | |
| JP2019131596A5 (https=) | ||
| CN110876259B (zh) | 注射用组合物 | |
| CA2522115A1 (en) | A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid | |
| JP7440630B2 (ja) | ウルソデオキシコール酸の注射用組成物 | |
| JP4378755B2 (ja) | ブチルフタリドとシクロデキストリンまたはその誘導体との包接複合体、それらの調製のためのプロセスおよびその使用 | |
| JP5256611B2 (ja) | クラドリビンの経口製剤 | |
| JP2022506069A (ja) | Ｂｃｌ－２阻害剤のシクロデキストリンに基づく製剤 | |
| Singh et al. | Preparation and characterization of clopidogrel bisulfate-hydroxypropyl-β-cyclodextrin mixed inclusion complex for improved intestinal solubility and anti-thrombotic efficacy | |
| JP2022510947A5 (https=) | ||
| JP2006516642A (ja) | 薬物製剤およびメチル化シクロデキストリン結晶を用いた送達 | |
| JP2000507258A (ja) | ジクロフェナック／ガンマ―シクロデキストリン包接化合物 | |
| CN1477977A (zh) | N-(甲基乙基氨基羰基)-4-(3-甲基苯基氨基)-3-吡啶基磺酰胺及环状低聚糖的组合物 | |
| JPWO2020124090A5 (https=) | ||
| JPWO2020067453A5 (https=) | ||
| CN101137364B (zh) | 包含埃坡霉素的组合物及其制备方法 | |
| CN111107837A (zh) | 包含西普尼莫德的肠胃外制剂 | |
| WO2004054621A1 (en) | Water-soluble clathrates of ziprasidone and its salts, and the preparation methods therefor | |
| US20170368055A1 (en) | Methods for treating infections | |
| Walke et al. | Sulfobutylether β-cyclodextrin (SBE-β-CD): a breakthrough for solubility enhancement | |
| JPS58116423A (ja) | メタノプロスタサイクリン製剤組成物 | |
| CZ292125B6 (cs) | Estramustinové formulace se zlepšenými farmaceutickými vlastnostmi | |
| CN107793497A (zh) | 乳糖‑β‑环糊精的合成方法 | |
| JPWO2020002851A5 (https=) |